ArticleMolecules (Basel, Switzerland)2024

In Silico Design of Dual Estrogen Receptor and Hsp90 Inhibitors for ER-Positive Breast Cancer Through a Mixed Ligand/Structure-Based Approach.

Gabriele La Monica et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.